News

Learn more about the in-depth topics covered in the August 2024 print issue of Dermatology Times.

Learn more about the in-depth topics covered in the August 2024 supplement of Dermatology Times.

One hundred patients with AK rated their therapies with the TSQM and Likert scale, and shared their treatment needs regarding goals, cost, type, duration, and location.

A recent review highlighted how AI can be used to enhance diagnostic accuracy, consultations, treatment planning, and patient education.

By setting higher treatment goals, the AHEAD recommendations emphasize the importance of achieving optimal targets for both skin clearance and itch relief in atopic dermatitis.

Results from the study highlight that the therapy improves AD symptoms over time, with 71.9% of participants achieving substantial improvement.

Researchers say further studies are needed to understand the effects of photoactivation, if any, in combination with PRP.

Earlier this summer, Meghan Heberton, MD, emphasized the importance and growth of the subspecialty.

The AHEAD recommendations focus on achieving disease control in atopic dermatitis by allowing patients to identify key symptoms and clinicians to select matching outcomes to guide therapy, aiming for a higher standard of care.

The study found that after 4 weeks of using the action plan, AD severity decreased markedly, with many patients achieving mild AD status.

The findings support the idea that Botox can enhance emotional well-being and self-confidence, although it did not notably impact the quality of life.

Bullous pemphigoid in youth is rare and can be missed due to negative BP180 ELISA results, complicating timely diagnosis in children.

Approximately 8.8% of patients achieved complete response a year after onset of diphenylcyclopropenone therapy.

Biologics work by inhibiting inflammatory cytokines, but a small percentage of patients may experience “paradoxical psoriasis.”

At the conclusion of their roundtable event, Rocco Serrao, MD, FAAD; Latanya Benjamin, MD, FAAD; and Anthony Nuara, MD, PhD, discuss final considerations for tailoring vitiligo treatment plans.

A recent study found after 6 months, CGF therapy resulted in a sustained increase in terminal hair density without significant adverse events.

Researchers tailored screening and surveillance schedules to individual risk of patients.

Rates of infection did not correlate with disease severity, however.

Keep up with the latest headlines in dermatology from the past week, including the presence of toxic "forever chemicals" in artificial turf, commercial availability of apremilast in the US, and more.

In case you missed it, this week we had news about Pelage's novel PP405 in phase 2a for androgenetic alopecia, the availability of apremilast in the US for pediatric psoriasis, higher patient adherence with pre-filled risankizumab pens, and more.

Acne vulgaris has been reported as an adverse effect of GLP-1 receptor agonists by some patients.

A recent study found prefilled pens with concealed needles showed promise in reducing injection-related anxiety and improving patient adherence.

A comprehensive analysis of 71 studies revealed the highest lesion clearance and recurrence rates among individuals who had undergone surgery.

Autologous fat grafting may be able to treat alopecia by controlling inflammation, enhancing symptoms, and boosting hair density.

A recent study confirmed that collagen peptides effectively counteract age-related skin issues such as reduced density and increased dryness.

Researchers identified mistrust, social stigma, and language barriers as major obstacles for ethnic minorities in skin research.

After treatment with the topical JAK inhibitor, researchers reported significant improvement of lesional skin.

In a review, researchers reported that ethnicity plays a role in outcomes, presentations, and more for individuals with systemic sclerosis.

Anthony Nuara, MD, PhD, reviewed a case study of a 32-year-old professional makeup artist who was concerned about her depigmented patches affecting her livelihood.

The National Psoriasis Foundation's new report provides an overview of the health impacts of psoriasis, revealing significant issues in care and outcomes.